Spring Bank Pharmaceuticals, Inc.·4

Sep 14, 4:03 PM ET

Driscoll Martin J 4

4 · Spring Bank Pharmaceuticals, Inc. · Filed Sep 14, 2017

Insider Transaction Report

Form 4
Period: 2017-09-14
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2017-09-14$14.84/sh+1,000$14,84055,400 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION